Kiniksa Pharmaceuticals International, plc (KNSA) Capital expenditures 2017–2025
Kiniksa Pharmaceuticals International, plc (KNSA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$1.6MFY2025 · since FY2017: $69,000 → $1.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.6M | +466.1% |
| FY2024 | $277,000 | +113.1% |
| FY2023 | $130,000 | +23.8% |
| FY2022 | $105,000 | -74.7% |
| FY2021 | $415,000 | +46.6% |
| FY2020 | $283,000 | -91.2% |
| FY2019 | $3.2M | -39.5% |
| FY2018 | $5.3M | +7566.7% |
| FY2017 | $69,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice